Glancing behind virus load variation in HIV-1 infection.

Although the steady-state virus load during HIV-1 infection is remarkably stable within a patient, it displays variation over several orders of magnitude between patients. Despite intensive research, the host and virus factors that are responsible for the observed variation remain poorly understood. Comparison of model predictions with clinical data suggests that most of the variation in steady-state virus load between patients reflects variation of the net rate at which activated CD4 cells are produced.

[1]  V. Calvez,et al.  HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. , 1999, AIDS.

[2]  Alan S. Perelson,et al.  Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.

[3]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[4]  P. Vernazza,et al.  Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study. , 2000 .

[5]  C. Yoder,et al.  Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression , 2000, AIDS.

[6]  Athanasius F. M. Marée,et al.  Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[7]  M A Nowak,et al.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.

[8]  A. Trkola,et al.  Residual Cell-Associated Unspliced HIV-1 Rna in Peripheral Blood of Patients on Potent Antiretroviral Therapy Represents Intracellular Transcripts , 2001, Antiviral therapy.

[9]  M. Lederman,et al.  Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points. , 1999, The Journal of infectious diseases.

[10]  H. Günthard,et al.  Human Immunodeficiency Virus-Specific CD8+ T-Cell Responses Do Not Predict Viral Growth and Clearance Rates during Structured Intermittent Antiretroviral Therapy , 2002, Journal of Virology.

[11]  A S Perelson,et al.  Improved estimates for HIV-1 clearance rate and intracellular delay. , 1999, AIDS.

[12]  Beda Joos,et al.  Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells. , 2001 .

[13]  John E. Mittler,et al.  Viral dynamics in primary HIV-1 infection , 2000 .

[14]  A. Perelson,et al.  Influence of delayed viral production on viral dynamics in HIV-1 infected patients. , 1998, Mathematical biosciences.

[15]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[16]  J. Montaner,et al.  Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. , 1996, The Journal of infectious diseases.

[17]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[18]  M. Schambelan,et al.  Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. , 1997, The Journal of infectious diseases.

[19]  M A Nowak,et al.  Competition between zidovudine‐sensitive and zidovudine‐resistant strains of HIV , 1992, AIDS.

[20]  A S Perelson,et al.  Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.

[21]  L M Wahl,et al.  Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A S Perelson,et al.  Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.

[23]  C. Sabin,et al.  Course of viral load throughout HIV-1 infection. , 2000 .

[24]  A. Telenti,et al.  A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. , 2003, Archives of internal medicine.

[25]  M A Nowak,et al.  Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A S Perelson,et al.  Target cell limited and immune control models of HIV infection: a comparison. , 1998, Journal of theoretical biology.

[27]  T. Elbeik,et al.  Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.

[28]  J J Goedert,et al.  Longitudinal HIV-1 RNA levels in a cohort of homosexual men. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[29]  A S Perelson,et al.  Rate of HIV‐1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen , 1998, AIDS.

[30]  R. Weber,et al.  Effects of Early Antiretroviral Treatment on HIV‐1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy , 2000, Journal of acquired immune deficiency syndromes.

[31]  Alan S. Perelson,et al.  Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen , 1998, The Journal of experimental medicine.

[32]  M A Nowak,et al.  Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[34]  Alan S. Perelson,et al.  Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy , 2001, The Journal of experimental medicine.

[35]  Martin A. Nowak,et al.  Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA , 1999, The Journal of experimental medicine.

[36]  Z. Grossman,et al.  Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Alan S. Perelson,et al.  A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo , 2003, Journal of Virology.

[38]  C H Fox,et al.  Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.

[39]  Douglas D. Richman,et al.  Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.

[40]  Sebastian Bonhoeffer,et al.  HIV results in the frame , 1995, Nature.